Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

GLPG

Galapagos (GLPG)

Galapagos

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:EU:GLPG

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next >>

Date	Time	Source	Headline	Symbol	Company
11/11/2022	7:15AM	GlobeNewswire Inc.	Galapagos announces CHMP adoption of PRAC’s recommendation for Jyseleca® following extensive safety review of all JAK inhibitors	EU:GLPG	Galapagos
11/11/2022	7:15AM	GlobeNewswire Inc.	Galapagos announces CHMP adoption of PRAC’s recommendation for Jyseleca® following extensive safety review of all JAK inhibitors	EU:GLPG	Galapagos
11/08/2022	4:01PM	GlobeNewswire Inc.	Galapagos to present encouraging initial data from FILOSOPHY real-world arthritis study at ACR Convergence 2022	EU:GLPG	Galapagos
11/08/2022	4:01PM	GlobeNewswire Inc.	Galapagos to present encouraging initial data from FILOSOPHY real-world arthritis study at ACR Convergence 2022	EU:GLPG	Galapagos
11/04/2022	4:01PM	GlobeNewswire Inc.	Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022	EU:GLPG	Galapagos
11/03/2022	4:01PM	GlobeNewswire Inc.	Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results	EU:GLPG	Galapagos
10/17/2022	1:30AM	GlobeNewswire Inc.	Galapagos to host its R&D Update 2022 in New York on 4 November 2022	EU:GLPG	Galapagos
10/17/2022	1:30AM	GlobeNewswire Inc.	Galapagos to host its R&D Update 2022 in New York on 4 November 2022	EU:GLPG	Galapagos
10/06/2022	4:01PM	GlobeNewswire Inc.	Galapagos provides further insights into the treatment of ulcerative colitis at the upcoming United European Gastroenterology (UEG) Week 2022 congress	EU:GLPG	Galapagos
10/06/2022	4:01PM	GlobeNewswire Inc.	Galapagos provides further insights into the treatment of ulcerative colitis at the upcoming United European Gastroenterology (UEG) Week 2022 congress	EU:GLPG	Galapagos
10/03/2022	4:01PM	GlobeNewswire Inc.	Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies	EU:GLPG	Galapagos
10/03/2022	4:01PM	GlobeNewswire Inc.	Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies	EU:GLPG	Galapagos
09/27/2022	4:01PM	GlobeNewswire Inc.	Galapagos increases share capital through subscription right exercises	EU:GLPG	Galapagos
09/27/2022	4:01PM	GlobeNewswire Inc.	Galapagos increases share capital through subscription right exercises	EU:GLPG	Galapagos
08/29/2022	4:01PM	GlobeNewswire Inc.	Galapagos receives transparency notification from FMR LLC	EU:GLPG	Galapagos
08/29/2022	4:01PM	GlobeNewswire Inc.	Galapagos receives transparency notification from FMR LLC	EU:GLPG	Galapagos
08/24/2022	4:01PM	GlobeNewswire Inc.	Galapagos to present at upcoming investor conferences	EU:GLPG	Galapagos
08/24/2022	4:01PM	GlobeNewswire Inc.	Galapagos to present at upcoming investor conferences	EU:GLPG	Galapagos
08/18/2022	4:01PM	GlobeNewswire Inc.	Galapagos receives transparency notification from FMR LLC	EU:GLPG	Galapagos
08/18/2022	4:01PM	GlobeNewswire Inc.	Galapagos receives transparency notification from FMR LLC	EU:GLPG	Galapagos
08/08/2022	4:01PM	GlobeNewswire Inc.	Galapagos receives transparency notification from FMR LLC	EU:GLPG	Galapagos
08/08/2022	4:01PM	GlobeNewswire Inc.	Galapagos receives transparency notification from FMR LLC	EU:GLPG	Galapagos
08/04/2022	4:01PM	GlobeNewswire Inc.	First key steps in pipeline rebuild and strong commercial progress in H1 2022	EU:GLPG	Galapagos
08/04/2022	4:01PM	GlobeNewswire Inc.	First key steps in pipeline rebuild and strong commercial progress in H1 2022	EU:GLPG	Galapagos
06/21/2022	4:03PM	GlobeNewswire Inc.	Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies	EU:GLPG	Galapagos
06/21/2022	4:03PM	GlobeNewswire Inc.	Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies	EU:GLPG	Galapagos
06/20/2022	4:01PM	GlobeNewswire Inc.	Galapagos increases share capital through subscription right exercises	EU:GLPG	Galapagos
06/20/2022	4:01PM	GlobeNewswire Inc.	Galapagos increases share capital through subscription right exercises	EU:GLPG	Galapagos
06/01/2022	4:01PM	GlobeNewswire Inc.	Galapagos receives transparency notification from FMR LLC	EU:GLPG	Galapagos
06/01/2022	4:01PM	GlobeNewswire Inc.	Galapagos receives transparency notification from FMR LLC	EU:GLPG	Galapagos

Showing the most relevant articles for your search:EU:GLPG

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next >>

Canopus Biopharma (PK)

Gold and GemStone Mining (PK)

Marketing Worldwide (PK)

Virexit Technologies (PK)

Bell Buckle (PK)

Brookmount Explorations (PK)

Ubiquitech Software (PK)

NioCorp Developments

Anavex Life Sciences

Decentral Life (PK)

Fannie Mae (QB)

Seven Arts Entertainment (PK)

Delayed Upgrade Clock